Loading...

Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD

One of the main problems in oncology is the development of drugs that cause the death of cancer cells without damaging normal cells. Another key problem to be solved is to suppress the drug resistance of cancer cells. The third important issue is to provide effective penetration of drug molecules to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Mol Sci
Main Authors: Fadeev, Roman, Chekanov, Alexey, Solovieva, Marina, Bezborodova, Olga, Nemtsova, Elena, Dolgikh, Nadezda, Fadeeva, Irina, Senotov, Anatoly, Kobyakova, Margarita, Evstratova, Yana, Yakubovskaya, Raisa, Akatov, Vladimir
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6387460/
https://ncbi.nlm.nih.gov/pubmed/30691192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20030525
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!